New Search

Your search found 22 records, sorted by year and then date of acquisition.

1. Feasibility and Safety of Extended-Release Naltrexone Treatment of Opioid and Alcohol Use Disorder in HIV Clinics: A Pilot/Feasibility Randomized Trial. doc type doc type
  Korthuis, P. Todd ; Lum, Paula J. ; Vergara-Rodriguez, Pamela ; Ahamad, Keith ; Wood, Evan ; Kunkel, Lynn E. ; Oden, Neal L. ; Lindblad, Robert ; Sorensen, James L. ; Arenas, Virgilio ; Ha, Doan ; Mandler, Raul N. ; McCarty, Dennis
 Addiction 2017 (in press). [doi: 10.1111/add.13753].
 
2. CSAT/CTN Webinar: Adolescent/Youth Projects Updates. doc type
  Johnson, Kimberly ; Fishman, Marc ; Levy, Sharon
 Webinar presented November 29, 2016.
 
3. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 
4. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
5. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
6. Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Matthews, Abigail G. ; Hillhouse, Maureen ; Thomas, Christie ; Ling, Walter ; Shmueli-Blumberg, Dikla
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
7. Utilizing a Two-Stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-Daily Bupropion as a Treatment for Methamphetamine Use Disorder. doc type
  Mooney, Larissa J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Ang, Alfonso ; Sharma, Gaurav ; Terry, Garth ; Chang, Linda ; Walker, N. Robrina ; Trivedi, Madhukar H. ; Croteau, David ; Sparenborg, Steven ; Ling, Walter
 Journal of Addiction Medicine 2016;10(4):236-243. [doi: 10.1097/ADM.0000000000000218].
 
8. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
9. Improving Treatment for Opioid Dependence: A Perspective from the Ohio Valley Node of the NIDA Clinical Trials Network. doc type
  Winstanley, Erin L. ; Brigham, Gregory S. ; Babcock, Dean ; Winhusen, Theresa M.
 Progress in Community Health Partnerships: Research, Education, and Action 2014;8(1):99-107. [doi: 10.1353/cpr.2014.0002].
 
10. Induction Onto Extended-Release Naltrexone in 302 Cocaine-Dependent Opioid Users. doc type
  Lindblad, Robert ; McCormack, Jennifer ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Mooney, Larissa ; VanVeldhuisen, Paul C. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
11. 2013 Texas Addiction Research to Practice Conference. doc type doc type
  Stotts, Angela L. ; Walters, Scott ; Wakhlu, Sidarth
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 26, 2013.
 
12. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. doc type
  Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
 Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].
 
13. Financial Factors Associated with Implementation of Medications for Addiction Treatment (MAT) for Alcohol Use Disorders. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Poster presented at the Addiction Health Services Research Conference (AHSR) conference, New York City, NY, October 17-19, 2012.
 
14. Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Journal of Addictive Medicine 2012;6(4):280-286. [doi: 10.1097/ADM.0b013e318262a97a].
 
15. Selective Review and Commentary on Emerging Pharmacotherapies for Opioid Addiction. doc type
  Ling, Walter ; Mooney, Larissa ; Zhao, Min ; Nielsen, Suzanne ; Torrington, Matthew ; Miotto, Karen
 Substance Abuse and Rehabilitation 2011;2:181-188. [doi: 10.2147/SAR.S20895].
 
16. Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. doc type
  Mooney, Larissa ; Saxon, Andrew J. ; Ling, Walter
 Webinar sponsored by the NIDA Clinical Coordinating Center, May 11, 2011.
 
17. Using Medication-Assisted Treatment for Substance Use Disorders: Evidence of Barriers and Facilitators of Implementation. doc type
  Roman, Paul M. ; Abraham, Amanda J. ; Knudsen, Hannah K.
 Addictive Behaviors 2011;36(6):584-589. [doi: 10.1016/j.addbeh.2011.01.032].
 
18. What the National Institute on Drug Abuse's Clinical Trials Network Can Do For You? Major Findings from Medication Trials and Implications for Community-Based Settings. doc type
  Weiss, Roger D.
 Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
 
19. Data from the CTN Platform Study: Major Findings. doc type
  Roman, Paul M. ; Abraham, Amanda J.
 Presentation from the CTN Steering Committee Meeting, March 2009; CTN 10th Anniversary Symposium, 2010, and the CTN Steering Committee Meeting, September 2010.
 
20. The Adoption of Alcohol Pharmacotherapies in the Clinical Trials Network: The Influence of Research Network Participation. doc type
  Abraham, Amanda J. ; Knudsen, Hannah K. ; Rothrauff, Tanja C. ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2010;38(3):275-283. [doi: 10.1016/j.jsat.2010.01.003].
 
21. Understanding Attitudes Toward Use of Medication in Substance Abuse Treatment: A Multilevel Approach. doc type
  Fitzgerald, John P. ; McCarty, Dennis
 Psychological Services 2009;6(1):74-84. [doi: 10.1037/a0013420].
 
22. Clinical Trials Network: Counselor-Level Data on Evidence-Based Treatment Practices. doc type
  Roman, Paul M. ; Johnson, J. Aaron ; Ducharme, Lori J. ; Knudsen, Hannah K.
 Atlanta, GA: Institute for Behavioral Research, University of Georgia, NTCS Report No. 11, February 2006, 44p..
 

New Search